NCT01336803 2023-12-27
Osteosarcoma
Stanford University
Phase 2 Completed
Clinical Trials
10 trialsNCT00978562 2022-08-03
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Completed
NCT00103038 2022-06-09
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
OHSU Knight Cancer Institute
Phase NA Completed
NCT02359097 2022-03-17
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
Phase NA Completed
NCT01815333 2020-10-19
Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging
M.D. Anderson Cancer Center
Phase NA Completed
NCT02253602 2019-01-16
IMPROVE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT02466828 2018-04-18
qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
Sunnybrook Health Sciences Centre
Phase EARLY_PHASE1 Completed
NCT02452216 2017-08-31
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Stanford University
Phase EARLY_PHASE1 Completed
NCT01927887 2017-06-06
Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study
Massachusetts General Hospital
Phase NA Completed
NCT00660543 2017-05-16
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
OHSU Knight Cancer Institute
Phase NA Completed